EpinaGen Tablet 10 mg (Epinastrine Hydrochloride)

Adult dose

1. Asthma, urticaria, eczema/dermatitis, skin itching, pruritic rash (prurigo), and common psoriasis accompanied by itching Adults: Administer 20 mg of epinastine hydrochloride orally once daily. Adjust the dose as appropriate according to symptoms. 2. Allergic rhinitis Adults: Administer 10～20 mg of this drug orally once daily. Adjust the dose as appropriate according to symptoms.

This medication should not be used by patients who are allergic to this medication or any of its ingredients. Additionally, it contains lactose, so it should not be taken by individuals with genetic conditions such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Patients with liver disease or a history of liver disease should be cautious, as the condition may worsen when using this medication. If allergic symptoms such as rash, urticaria, or swelling occur while taking this medication, stop taking it immediately and seek appropriate treatment. Occasionally, symptoms such as drowsiness, headache, dizziness, insomnia, and nightmares may occur, so caution is advised. Gastrointestinal symptoms such as nausea, abdominal pain, diarrhea, constipation, and dry mouth may occur, so patients should monitor their condition closely. Abnormal liver function or jaundice may occur, so regular liver function tests are necessary, and if any abnormal symptoms appear, consult a doctor immediately. Rarely, renal and urinary symptoms such as proteinuria, frequent urination, and hematuria may occur, so careful observation is required. Symptoms such as rapid heartbeat or difficulty breathing can also occur rarely, so inform medical personnel if these symptoms arise. This medication is not intended for immediate relief of asthma attacks, so patients with asthma should understand their acute symptom management adequately. Be cautious when driving or operating machinery as drowsiness may occur, and it is advisable not to take this medication long-term if it is ineffective. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and breastfeeding women should avoid taking it or stop breastfeeding if necessary. The safety for children, newborns, and infants has not been fully established. Elderly patients may have reduced liver and kidney function, and careful observation for adverse reactions is essential, adjusting the dosage if necessary. In case of overdose, cardiac abnormalities such as arrhythmias may occur, and if such an overdose happens, immediate medical attention is required. Keep this medication out of reach of children, and do not transfer it to another container. Additionally, taking this medication on an empty stomach may increase blood concentration, so follow the doctor's instructions regarding the timing and method of administration carefully.

Allergic reactions (rash, hives, redness), itching, swelling (face, limbs, etc.), erythema accompanied by itching, drowsiness, lethargy, headache, dizziness, insomnia, nightmares, numbness, feeling of dullness in the head, nausea, gastrointestinal discomfort, dry mouth, abdominal pain, loss of appetite, vomiting, feeling of heaviness in the stomach, feeling of fullness, diarrhea, constipation, dry lips, abdominal bloating, stomatitis, liver dysfunction, jaundice, exacerbation of symptoms of hepatitis and liver damage, proteinuria, frequent urination, hematuria, urinary retention, palpitations, dyspnea, difficulty in expectoration, nasal congestion, thrombocytopenia, leukocytosis, gynecomastia, breast enlargement, menstrual irregularities, flushing, bitter taste, decreased taste sensation, chest pain

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature to preserve its effectiveness.

Appearance

White or pale yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle